Skip to content

Trulieve Cannabis Corp. (TRLV) stock: revenue, earnings & dividend

Trulieve Cannabis Corp. (TRLV, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener TRLV · NYSE Pharma & Biotech US-FL

Key figures

Fiscal year
2025
Revenue
1.18 bn $
Revenue growth
-0.5 %
Revenue growth 5y (p.a.)
17.8 %
Net income
-116.38 m $
Net margin
-9.9 %
Operating margin
12.2 %
Earnings per share (diluted)
-0.58 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
2.7 bn $
Equity
1.14 bn $
Equity ratio
42.4 %
Return on equity
-10.2 %
Cash
256 m $
Operating cash flow
273 m $
Free cash flow
229 m $
Shares outstanding
–

History

Revenue by fiscal year

2019 253 m $
2020 522 m $
2021 932 m $
2022 1.22 bn $
2023 1.13 bn $
2024 1.19 bn $
2025 1.18 bn $

Net income by fiscal year

2019 53.1 m $
2020 63 m $
2021 18 m $
2022 -246.06 m $
2023 -526.8 m $
2024 -155.11 m $
2025 -116.38 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.18 bn $-116.38 m $-0.58 $–273 m $
20241.19 bn $-155.11 m $-0.79 $–271 m $
20231.13 bn $-526.8 m $-2.28 $–202 m $
20221.22 bn $-246.06 m $-0.95 $–23.1 m $
2021932 m $18 m $0.21 $–12.9 m $
2020522 m $63 m $0.53 $–99.6 m $
2019253 m $53.1 m $0.46 $–19.1 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)